109685 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Recombinant Adenovirus Having Anti-Angiogenesis Activity
#602Uniform field magnetization and targeting of therapeutic formulations
#603HEXON ISOLATED FROM SIMIAN ADENOVIRUS SEROTYPE 19, HYPERVARIABLE REGION THEREOF AND CHIMERIC ADENOVIRUS USING THE SAME
#604Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby
#605Uniform Field Magnetization and Targeting of Therapeutic Formulations
#606Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#607Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#608Chimpanzee adenovirus vaccine carriers
#609Methods and compositions for the inhibition of Stat5 in prostate cancer cells
#610METHODS OF GENE THERAPY FOR TREATING DISORDERS OF THE EAR BY ADMINISTERING A VECTOR ENCODING AN ATONAL-ASSOCIATED FACTOR
#611Modified INSM1-promoter for neuroendocrine tumor therapy and diagnostics
#612VIRAL AND NON-VIRAL VECTORS AS VEHICLES FOR DELIVERING TRANSGENES FOR TREATING BONE PATHOLOGIES
#613Methods and compositions for gene inactivation
#614Methods and compositions for gene inactivation
#615Therapeutic Use of Growth Factor, and Delivery Device, Especially for the Treatment of Intimal Hyperplasia
#616METHOD OF USING ADENOVIRAL VECTORS TO INDUCE AN IMMUNE RESPONSE
#617REPLICATING VIRAL VECTORS FOR GENE THERAPY
#618METHOD AND COMPOSITION FOR CREATING CONDITIONAL LETHALITY FOR VIRUS MUTANTS AND FOR ELIMINATING THE VIABILITY OF AN EUKARYOTIC CELL
#619Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein
#620Method for Enhancing Pancreatic Beta Cell Proliferation, Increasing Serum Insulin Concentration, Decreasing Blood Glucose Concentration And Treating And/Or Preventing Diabetes
#621Recombinant adenoviruses encoding the specific iodine transporter (NIS)
#622Early Growth Transcription Factors and Their Therapeutic Use
#623Method and Composition to Increase Radiation-Induced Tumor Therapeutic Effects
#624Composition for treating HBV infection
#625Chimeric adenoviruses for use in cancer treatment
#626Drug comprising as the active ingredient proliferative vector containing survivin promoter
#627Methods of propagating monkey adenoviral vectors
#628NUCLEIC ACID SEQUENCES ENCODING EXPANDABLE HIV MOSAIC PROTEINS
#629VIRUS LIKE PARTICLES COMPRISING TARGET PROTEINS FUSED TO PLANT VIRAL COAT PROTEINS
#630HIV-1 clade a consensus sequences, antigens, and transgenes
#631Adenovirus vaccine vector and methods of use
#632Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
#633Composition and Method for the Treatment or Prevention of Spinal Disorders III
#634SorCS1 for the treatment of obesity
#635INFECTIVITY-ENHANCED CONDITIONALLY-REPLICATIVE ADENOVIRUS AND USES THEREOF
#636Process for adenovirus purification from high cell density cultures
#637Method for the purification of adenovirus particles
#638Long lasting drug formulations
#639MICROBUBBLE ASSISTED VIRAL DELIVERY
#640Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses
#641Simian adenovirus 41 and uses thereof
#642Intracellular viral vector delivery method employing iron ion/viral vector composite
#643Cancer therapy
#644Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures
#645SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
#646Oncolytic adenoviruses for treating cancer
#647Multi-Cistronic shRNA Expression Cassette for Suppressing Single or Multiple Target Genes
#648Method for preventing and treating cardiovascular diseases with BRCA1
#649Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases
#650Induction of an immune response against dengue virus using the prime-boost approach
#651HUMAN MATRIX METALLOPROTEINASE-8 GENE DELIVERY ENHANCES THE ONCOLYTIC ACTIVITY OF A REPLICATING ADENOVIRUS
#652THERAPEUTIC REGIMEN FOR TREATING CANCER
#653Engineered Dendritic Cells and Uses for the Treatment of Cancer
#654CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
#655Simian Adenovirus Vectors and Methods of Use
#656Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#657COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#658Recombinant viral-based malaria vaccines
#659Chromosome 3p21.3 genes are tumor suppressors
#660Antiviral vaccines with improved cellular immunogenicity
#661NON-AD5 ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#662Stable, spray dryed, immunogenic, viral compositions
#663Adenovirus vectors
#664METHODS AND REAGENTS FOR EFFICIENT AND TARGETED GENE TRANSFER TO MONOCYTES AND MACROPHAGES
#665Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#666E1-MINUS ADENOVIRUSES AND USE THEREOF
#667ANTIBODY GENE TRANSFER AND RECOMBINANT AAV THEREFOR
#668Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#669Recombinant adenovirus vector having a reduced side effect
#670Vaccination methods
#671Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof
#672Recombinant adenovirus target-oriented co-expressing human p53 and p53aip1
#673THERAPEUTIC AGENT COMPRISING VASOHIBIN
#674Long lasting drug formulations
#675POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA
#676Tumor selective E1a and E1b mutants
#677Settings for recombinant adenoviral-based vaccines
#678RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE
#679Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#680Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
#681Optogenetic method for generating an inhibitory current in a mammalian neuron
#682GENE THERAPY VECTOR FOR TREATMENT OF STEROID GLAUCOMA
#683Porcine Adenovirus 3-Based PRRSV Vaccines
#684Recombinant vectors and hosts comprising human glucokinase encoding gene
#685Long lasting drug formulations
#686CARDIAC ARRHYTHMIA TREATMENT METHODS AND BIOLOGICAL PACEMAKER
#687Methods and compositions for treating neuropathic and neurodegenerative conditions
#688Multivalent vaccines comprising recombinant viral vectors
#689VIRAL AND NON-VIRAL VECTORS AS VEHICLES FOR DELIVERING TRANSGENES FOR TREATING BONE PATHOLOGIES
#690NOVEL USE OF ADENOVIRUSES AND NUCLEIC ACIDS THAT CODE FOR SAID VIRUSES
#691HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV
#692Engineered cells expressing multiple immunomodulators and uses thereof
#693IMMUNIZATION OF AVIANS BY MUCOSAL ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES
#694RECOMBINANT ADENOVIRUS COMPRISING TISSUE-SPECIFIC PROMOTER AND TUMOR-TARGETING TRANS-SPLICING RIBOZYME AND USES THEREOF
#695Multivalent vaccines comprising recombinant viral vectors
#696Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
#697FOCAL CALCIUM CHANNEL MODULATION
#698MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS
#699MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS
#700Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
#701Generation of replication competent viruses for therapeutic use
#702Chimpanzee adenovirus vaccine carriers
#703METHOD FOR ENHANCING AN IMMUNE RESPONSE
#704PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS
#705Method for the production of adenoviral vectors
#706REPLICATION COMPETENT VIRUSES CAPABLE OF SILENCING VIRUS INHIBITORY FACTOR EXPRESSION
#707Production of rAAV in Vero Cells Using Particular Adenovirus Helpers
#708In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#709In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#710Peptides that target dorsal root ganglion neurons
#711ADENOVIRUS PARTICLES HAVING A CHIMERIC ADENOVIRUS SPIKE PROTEIN, USE THEREOF AND METHODS FOR PRODUCING SUCH PARTICLES
#712Vaccination with multiple clades of H5 influenza A virus
#713VACCINATION REGIMEN
#714USE OF AAV INTEGRATION EFFICIENCY ELEMENT FOR MEDIATING SITE-SPECIFIC INTEGRATION OF A TRANSCRIPTION UNIT
#715ADENOVIRUS TARGETING
#716Vaccine
#717METHODS AND REAGENTS FOR VACCINATION WHICH GENERATE A CD8 T CELL IMMUNE RESPONSE
#718Recombinant viral-based malaria vaccines
#719Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator
#720Shortened Alk1 regulatory fragment
#721Methods and Compositions for Increasing Titer of Recombinant Porcine Adenovirus-3 Vectors
#722Settings for recombinant adenoviral-based vaccines
#723Reduction of dermal scarring
#724Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#725VACCINE FOR THE PREVENTION AND THERAPY OF HCV INFECTIONS
#726Use of mTOR inhibitors to enhance T cell immune responses
#727Adenoviral-based vectors
#728Method of suppressing gene transcription through histone lysine methylation
#729TAPASIN AUGMENTATION FOR ENHANCED IMMUNE RESPONSE
#730ENHANCEMENT OF TRANSGENE EXPRESSION FROM VIRAL-BASED VACCINE VECTORS BY EXPRESSION OF SUPPRESSORS OF THE TYPE I INTERFERON RESPONSE
#731Telomelysin/GFP-expressing recombinant virus
#732TREATMENT OF PARKINSON'S DISEASE
#733METHODS AND COMPOSITIONS FOR THE DELIVERY OF VACCINES TO DISRUPTED EPITHELIUM
#734Treatment of parkinson's disease via administration of GLI-1 protein
#735VACCINES FOR PREVENTION AND TREATMENT OF ADDICTION
#736SYSTEM FOR PACKAGING HIGH-CAPACITY ADENOVIRUSES
#737AEROSOLIZED GENETIC VACCINES AND METHODS OF USE
#738Chimeric adenoviral vectors
#739MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
#740ADAPTER MOLECULE FOR THE DELIVERY OF ADENOVIRUS VECTORS
#741SELF-INACTIVATING HELPER ADENOVIRUSES FOR THE PRODUCTION OF HIGH-CAPACTIY RECOMBINANT ADENOVIRUSES
#742Mesothelioma Specific Transferred Promoter And Use Thereof
#743Immunogenic Compositions
#744Capsid-Incorporated Antigen for Novel Adenovirus Vaccine
#745C/CLP Antagonists And Methods Of Use Thereof
#746Adenoviruses Mutated In The VA Genes For Cancer Treatment
#747Materials and methods for prevention and treatment of RNA viral diseases
#748Non-Aggregating Virus Formulation
#749Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#750Adjuvant
#751Oncolytic virus replicating selectively in tumor cells
#752THERAPEUTIC REGIMEN FOR TREATING CANCER
#753Production of viral vectors
#754Use of adenovirus and nucleic acids coding therefor
#755METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION
#756Targeted integration into stem cells
#757Single cycle replicating adenovirus vectors
#758HIV COMBINATION VACCINE AND PRIME BOOST
#759Human respiratory syncytial virus (RSV) vaccine
#760Use of FLJ25416 gene
#761Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof
#762Decoy-containing pharmaceutical compositions and method of using the same
#763ADENOVIRAL SYSTEMS AND THE USES THEREOF
#764SYN3 compositions and methods
#765Conditionally Replicating Viruses for Cancer Therapy
#766Combination Immunogene Therapy
#767Packaging cells for recombinant adenovirus
#768NOVEL USE OF ADENOVIRUSES AND NUCLEIC ACIDS THAT CODE FOR SAID VIRUSES
#769ANTI-HCV VACCINE AND PREPARATION METHODS AND USES THEREOF
#770Adeno-Associated Virus Materials and Methods
#771treatment
#772Development of a preventive vaccine for filovirus infection in primates
#773Development of a preventive vaccine for filovirus infection in primates
#774POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA
#775Adenoviruses, nucleic acids that code for the same and the use of said viruses
#776Development of a preventive vaccine for filovirus infection in primates
#777INDUCING IMMUNE-MEDIATED TUMOR CELL DEATH
#778Modified viral vector particles
#779Compositions and Methods
#780Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis
#781Diagnosis of mood disorders by detecting latent infection with human herpesvirus-6
#782PURIFICATION OF ADENOVIRUS AND AAV
#783NUCLEOTIDE VACCINE
#784VACCINE
#785Recombinant Adenovirus Vaccines
#786Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome
#787Methods and compositions for treatment of interferon-resistant tumors
#788Selectively replicating viral vectors
#789Simian subfamily C adenoviruses SAdV-40, -31, and -34 and uses thereof
#790Uniform field magnetization and targeting of therapeutic formulations
#791Methods and compositions for treating neuropathic and neurodegenerative conditions
#792Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof
#793In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#794Codon modified immunogenic compositions and methods of use
#795Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38
#796In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#797Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#798ENZYME-PRODRUG THERAPY FOR PROSTHETIC JOINT REPAIR
#799COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#800CHIMERIC ADENOVIRUS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL USING THE SAME
#801Recombinant adenovirus useful for treating malignancy over-expressing proto-oncogene neu/erb B2
#802Recombinant adenoviruses capable of regulating angiogenesis
#803COMPOSITIONS AND METHODS FOR TREATING INTRACELLULAR DISEASES
#804HSV-1 epitopes and methods for using same
#805METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS
#806VIRAL VECTOR FOR GENE THERAPY
#807MODIFIED DENDRITIC CELLS HAVING ENHANCED SURVIVAL AND IMMUNOGENICITY AND RELATED COMPOSITIONS AND METHODS
#808Compositions and methods for retinal transduction and photoreceptor specific transgene expression
#809Sequential administration of a replication defective adenovirus vector in vaccination protocols
#810Broadly Representative Antigen Sequences and Method for Selection
#811METHOD FOR PRODUCING ADENOVIRUS VECTORS FOR GENE THERAPY AND DNA SEQUENCES USED THEREFOR
#812Recombinant viral-based malaria vaccines
#813HLA-A2-RESTRICTED T-CELL EPITOPES OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN AS PEPTIDE-BASED VACCINES
#814Methods of using angiopoietin-like 4 protein to stimulate proliferation of pre-adipocytes
#815Adenoviral vectors and methods and uses related thereto
#816Vaccine against pandemic strains of influenza viruses
#817TARGETED TUMOR THERAPY BY USE OF RECOMBINANT ADENOVIRUS VECTORS THAT SELECTIVELY REPLICATE IN HYPOXIC REGIONS OF TUMORS
#818PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION
#819Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
#820Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof
#821Generation of oncolytic adenoviruses and uses thereof
#822Hepatitis C virus vaccine
#823Adenovirus with mutations in the endoplasmic reticulum retention domain of the E3-19K protein and their use in cancer treatment
#824Methods and compositions for the inhibition of Stat5 in prostate cancer cells
#825Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
#826Methods and reagents for vaccination which generate a CD8 T cell immune response
#827ISOLATED DNA FRAGMENT OF THE HUMAN A33 PROMOTER AND ITS USE TO CONTROL THE EXPRESSION OF A HETEROLOGOUS GENE IN TUMOR CELLS
#828THERAPEUTIC AGENT COMPRISING VASOHIBIN
#829HIV vaccines based on Env of multiple clades of HIV
#830RSV F-protein and its use
#831Methods and compositions for gene inactivation
#832Method for the production and purification of adenoviral vectors
#833Method of adenoviral vector synthesis
#834Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors
#835Method for preventing and treating cardiovascular diseases with BRCA1
#836ENHANCING DISEASE RESISTANCE AGAINST RNA VIRAL INFECTIONS WITH INTRACYTOPLASMIC PATHOGEN SENSORS
#837Oncolytic Adenoviruses and Uses Thereof
#838Regulation of angiogenesis with zinc finger proteins
#839Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#840RECOMBINANT ADENOVIRUSES ENCODING THE SPECIFIC IODINE TRANSPORTER (NIS)
#841AVIAN INFLUENZA VACCINE
#842METHOD FOR THE PRODUCTION AND PURIFICATION OF RETROVIRAL VECTORS
#843Cardiac hypertrophy
#844NOVEL METHOD AND COMPOSITIONS
#845Method of accelerated vaccination against Ebola viruses
#846Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor GM-CSF in tumor cells and uses thereof
#847Replication-competent anti-cancer vectors
#848RECOMBINANT ADENOVIRUS COMPRISING RECOMBINANT khp53 GENE AND THE PREPARATION METHOD AND USES THEREOF
#849Serotype of adenovirus and uses thereof
#850METHOD FOR CONSTRUCTING MICRORNA ADENOVIRUS EXPRESSION PLASMIDS OF SEVERE HEPATITIS RELATED HFGL2, HFAS AND HTNFR1 GENES AND PHARMACEUTICAL USE THEREOF
#851Combination Approaches For Generating Immune Responses
#852Settings for recombinant adenoviral-based vaccines
#853LIPOSOMALLY ENCAPSULATED HYBRID ADENOVIRUS-SEMLIKI FOREST VIRUS (SFV) VECTORS CARRYING RNAI CONSTRUCTS AND THERAPEUTIC GENES FOR USE AGAINST CANCER TARGETS AND OTHER DISEASES
#854Vaccines for the Rapid Response to Pandemic Avian Influenza
#855PORCINE ADENOVIRUS E1 AND E4 REGIONS
#856Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#857Adenoviral expression vectors
#858Method for Enhancing Pancreatic Beta Cell Proliferation, Increasing Serum Insulin Concentration, Decreasing Blood Glucose Concentration And Treating And/Or Preventing Diabetes
#859Methods and reagents for vaccination which generate a CD8 T cell immune response
#860FUSION MULTIVIRAL CHIMERIC ANTIGEN
#861Oncolytic Adenoviruses for Cancer Treatment
#862Chimeric vaccine antigens against classical swine fever virus
#863Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
#864Method of using adenoviral vectors to induce an immune response
#865RECOMBINANT VACCINE AGAINST JAPANESE ENCEPHALITIS VIRUS (JEV) INFECTION AND A METHOD THEREOF
#866Methods and compositions for cancer therapy using a novel adenovirus
#867Inhibition of the liver tropism of adenoviral vectors
#868Production of rAAV in vero cells using particular adenovirus helpers
#869NOVEL RECOMBINANT AND MUTANT ADENOVIRUSES
#870Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
#871WWOX Vectors and Uses in Treatment of Cancer
#872Enhanced antiviral activity against foot and mouth disease
#873Adenoviral vector-based foot-and-mouth disease vaccine
#874HYBRID ADENO-RETROVIRAL VECTOR FOR THE TRANSFECTION OF CELLS
#875Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
#876Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
#877COMPOSITIONS AND METHODS RELATED TO AN ADENOVIRAL TRANS-COMPLEMENTING CELL LINE
#878TREATING HEART FAILURE AND VENTRICULAR ARRHYTHMIAS
#879Production of vaccines
#880In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#881Hepatitis C virus vaccine
#882Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector
#883E1-MINUS ADENOVIRUSES AND USE THEREOF
#884CELLS FOR ADENOVIRUS VECTOR AND PROTEIN PRODUCTION
#885Chimeric adenoviruses for use in cancer treatment
#886Recombinant porcine adenovirus vector
#887INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE
#888Compounds and methods for inhibiting hepatitis C virus replication
#889Simian adenovirus vectors and methods of use
#890Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases
#891Generation of Replication Competent Viruses for Therapeutic Use
#892ANTIVIRAL AGENTS AND VACCINES AGAINST INFLUENZA
#893Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling
#894TREATMENT OF EPSTEIN-BARR VIRUS-ASSOCIATED DISEASES
#895ADENOVIRUS VACCINE UTILIZING IKK AS ADJUVANT
#896ADENOVIRUSES MUTATED IN THE VA GENES FOR CANCER TREATMENT
#897CANCER-SPECIFIC PROMOTERS
#898Antibody fragment-targeted immunoliposomes for systemic gene delivery
#899Methods and reagents for vaccination which generate A CD8 T cell immune response
#900Hepatitis C virus non structural fusion protein